A doctor discusses a neglected treatment option for opioid addiction: medical marijuana.
Neuroscientist Greg Gerdeman challenges researchers to study cannabis science and therapeutics.
The 2016 meeting of ICRS focused on the latest cannabinoid research and the endocannabinoid system.
Dr. Ethan Russo discusses clinical endocannabinoid deficiency and ways to target the ECS for therapeutic benefit.
Low-dose and high-dose treatments, protocols for chronic users, and the potential benefits of psychoactivity.
A survey of 300 patients suggests that cannabis is better than Big Pharma for common PTSD symptoms.
Kevin McKernan discusses sequencing the cannabis genome and its implications.
Here’s what we learned when we asked thousands of patients about their use of CBD.
THC has been the focus of cannabis research. Today, the contributions of CBD and terpenes are being explored.
The misnamed “Smart Approaches to Marijuana” seeks to justify prohibition with misinformation.